NCT02970019View on ClinicalTrials.gov

Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 30, 2017

Primary Completion Date

May 28, 2019

Study Completion Date

May 28, 2019

Conditions
Parkinson Disease
Interventions
DRUG

K0706

Once a day administration after fast

DRUG

Placebo

Once a day administration after fast

Trial Locations (5)

27612

SPARC Site 04, Raleigh

32720

SPARC Site 01, DeLand

32806

SPARC Site 02, Orlando

90806

SPARC Site 03, Long Beach

91402

SPARC Site 05, Panorama City

All Listed Sponsors
lead

Sun Pharma Advanced Research Company Limited

INDUSTRY

NCT02970019 - Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease | Biotech Hunter | Biotech Hunter